Page 1653 - Hematology_ Basic Principles and Practice ( PDFDrive )

1472.e2 Part VII Hematologic Malignancies

48. Ferrell B, Grant M, Schmidt GM, et al: The meaning of quality of life 72. Tang ST, McCorkle R: Determinants of place of death for terminal
for bone marrow transplant survivors. Part 2. Improving quality of life cancer patients. Cancer Invest 19:165–180, 2001.
for bone marrow transplant survivors. Cancer Nurs 15:247–253, 1992. 73. Manitta VJ, Philip JA, Cole-Sinclair MF: Palliative care and the hemato-
49. Ferrell B, Grant M, Schmidt GM, et al: The meaning of quality of oncological patient: can we live together? A review of the literature.
life for bone marrow transplant survivors. Part 1. The impact of bone J Palliat Med 13:1021–1025, 2010.
marrow transplant on quality of life. Cancer Nurs 15:153–160, 1992. 74. Bishop MR, Logan BR, Gandham S, et al: Long-term outcomes of
50. Hewitt M, Sheldon G, Stovall E: From cancer patient to cancer survivor: adults with acute lymphoblastic leukemia after autologous or unrelated
lost in transition, Washington, DC, 2006, National Academy Press. donor bone marrow transplantation: a comparative analysis by the
51. Bokemeyer C: [Late damage of curative oncologic therapy. Results of National Marrow Donor Program and Center for International Blood
a patient sample with Hodgkin’s disease and testicular tumors at the and Marrow Transplant Research. Bone Marrow Transplant 41:635–642,
Hannover Medical School]. Med Klin 91(Suppl 3):60–67, 1996. 2008.
52. Bush NE, Haberman M, Donaldson G, et al: Quality of life of 125 75. Evan EE, Zeltzer LK: Psychosocial dimensions of cancer in adolescents
adults surviving 6-18 years after bone marrow transplantation. Soc Sci and young adults. Cancer 107:1663–1671, 2006.
Med 40:479–490, 1995. 76. Keller M, Heinrich G, Sellschopp A, et al: Between distress and support:
53. Schimmer AD, Elliott ME, Abbey SE, et al: Illness intrusiveness among spouses of cancer patients. In Baider L, Cooper CL, Kaplan De-Nour
survivors of autologous blood and marrow transplantation. Cancer A, editors: Cancer and the family, Oxford, England, 1996, John Wiley
92:3147–3154, 2001. & Sons, pp 187–223.
54. Persson L, Hallberg IR, Ohlsson O: Survivors of acute leukaemia and 77. Extermann M: Measuring comorbidity in older cancer patients. Eur J
highly malignant lymphoma–retrospective views of daily life problems Cancer 36:453–471, 2000.
during treatment and when in remission. J Adv Nurs 25:68–78, 1997. 78. Yancik R, Ries LA: Aging and cancer in America. Demographic and
55. Wellisch DK, Centeno J, Guzman J, et al: Bone marrow transplantation epidemiologic perspectives. Hematol Oncol Clin North Am 14:17–23,
vs. high-dose cytorabine-based consolidation chemotherapy for acute 2000.
myelogenous leukemia. A long-term follow-up study of quality-of-life 79. McGrath P: End-of-life care for hematological malignancies: the
measures of survivors. Psychosomatics 37:144–154, 1996. ‘technological imperative’ and palliative care. J Palliat Care 18:39–47,
56. Molassiotis A, van den Akker OB, Milligan DW, et al: Quality of life 2002.
in long-term survivors of marrow transplantation: comparison with a 80. Knobel H, Loge JH, Nordoy T, et al: High level of fatigue in lym-
matched group receiving maintenance chemotherapy. Bone Marrow phoma patients treated with high dose therapy. J Pain Symptom Manage
Transplant 17:249–258, 1996. 19:446–456, 2000.
57. Zittoun R, Suciu S, Watson M, et al: Quality of life in patients with 81. Misono S, Weiss NS, Fann JR, et al: Incidence of suicide in persons
acute myelogenous leukemia in prolonged first complete remission with cancer. J Clin Oncol 26:4731–4738, 2008.
after bone marrow transplantation (allogeneic or autologous) or che- 82. Johnson Vickberg SM, Duhamel KN, Smith MY, et al: Global meaning
motherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A and psychological adjustment among survivors of bone marrow trans-
trial. Bone Marrow Transplant 20:307–315, 1997. plant. Psychooncology 10:29–39, 2001.
58. Wettergren L, Langius A, Bjorkholm M, et al: Post-traumatic stress 83. Jenkins PL, Lester H, Alexander J, et al: A prospective study of
symptoms in patients undergoing autologous stem cell transplantation. psychosocial morbidity in adult bone marrow transplant recipients.
Acta Oncol 38:475–480, 1999. Psychosomatics 35:361–367, 1994.
59. Emanuel EJ, Emanuel LL: The promise of a good death. Lancet 84. Andrykowski MA: Psychosocial Factors in Bone-Marrow Transplanta-
351(Suppl 2):SII21–SII29, 1998. tion - a Review and Recommendations for Research. Bone Marrow
60. Dow KH: The enduring seasons in survival. Oncol Nurs Forum Transplant 13:357–375, 1994.
17:511–516, 1990. 85. Tschuschke V, Hertenstein B, Arnold R, et al: Associations between
61. Mellon S, Northouse LL: Family survivorship and quality of life fol- coping and survival time of adult leukemia patients receiving allogeneic
lowing a cancer diagnosis. Res Nurs Health 24:446–459, 2001. bone marrow transplantation: results of a prospective study. J Psychosom
62. Widows MR, Jacobsen PB, Fields KK: Relation of psychological vulner- Res 50:277–285, 2001.
ability factors to posttraumatic stress disorder symptomatology in bone 86. Molassiotis A, Van Den Akker OB, Milligan DW, et al: Symptom
marrow transplant recipients. Psychosom Med 62:873–882, 2000. distress, coping style and biological variables as predictors of survival
63. Andrykowski MA, Cordova MJ, Studts JL, et al: Posttraumatic stress after bone marrow transplantation. J Psychosom Res 42:275–285, 1997.
disorder after treatment for breast cancer: prevalence of diagnosis and 87. Hoppe RT, Advani RH, Bierman PJ, et al: Hodgkin disease/lymphoma.
use of the PTSD Checklist-Civilian Version (PCL-C) as a screening Clinical practice guidelines in oncology. J the National Comprehensive
instrument. J Consult Clin Psychol 66:586–590, 1998. Cancer Network. JNCCN 4:210–230, 2006.
64. Jacobsen P: State of the science: Psychological well-being and survivorship. 88. Li XH, Sun L, Yuan J: [Application of WHO classification and NCCN
Survivorship Education for Quality Cancer Care Conference; 2006; guidelines in diagnosis of lymphoma]. Zhonghua Bing Li Xue Za Zhi
City of Hope, Duarte, CA. 38:217–220, 2009.
65. Patrick DL, Engelberg RA, Curtis JR: Evaluating the quality of dying 89. Frick E, Motzke C, Fischer N, et al: Is perceived social support a
and death. J Pain Symptom Manage 22:717–726, 2001. predictor of survival for patients undergoing autologous peripheral
66. Steinhauser KE, Christakis NA, Clipp EC, et al: Factors considered blood stem cell transplantation? Psychooncology 14:759–770, 2005.
important at the end of life by patients, family, physicians, and other 90. Lim JW, Zebrack B: Social networks and quality of life for long-term
care providers. JAMA 284:2476–2482, 2000. survivors of leukemia and lymphoma. Support Care Cancer 14:185–192,
67. Coyle N: Introduction to palliative nursing care. In Ferrell B, Coyle 2006.
N, editors: Textbook of palliative nursing, New York, 2006, Oxford 91. Leigh S, Wilson KC, Burns R, et al: Psychosocial morbidity in bone
University Press, p 1. marrow transplant recipients: a prospective study. Bone Marrow Trans-
68. Paice J, Fine P: Pain at the end of life. In Ferrell B, Coyle N, editors: plant 16:635–640, 1995.
Textbook of pallaitive nursing, New York, 2006, Oxford University Press, 92. Andrykowski MA, Brady MJ, Greiner CB, et al: ‘Returning to normal’
p 131. following bone marrow transplantation: outcomes, expectations and
69. McGrath P: Update on psychosocial research on leukaemia for social informed consent. Bone Marrow Transplant 15:573–581, 1995.
work practitioners. Soc Work Health Care 29:1–20, 1999. 93. Loge JH, Abrahamsen AF, Ekeberg, et al: Fatigue and psychiatric
70. Maddocks I, Bentley L, Sheedy J: Quality of life issues in patients dying morbidity among Hodgkin’s disease survivors. J Pain Symptom Manage
from haematological diseases. Ann Acad Med Singapore 23:244–248, 19:91–99, 2000.
1994. 94. Hjermstad MJ, Evensen SA, Kvaloy SO, et al: Health-related quality
71. Institute of Medicine: Approaching death: improving care at the end of of life 1 year after allogeneic or autologous stem-cell transplantation: a
life, Washington, DC, 1997, National Academy Press. prospective study. J Clin Oncol 17:706–718, 1999.